Evaluation of myocardial perfusion and fatty acid uptake using a single injection of iodine-123-BMIPP in patients with acute coronary syndromes

Journal of Nuclear Medicine

Volumn 39, Issue 7, 1998, Pages 1117-1122

  Kobayashi, Hideki ^a,b   Kusakabe, Kiyoko ^a   Momose, Mitsuru ^a   Okawa, Tomohiko ^a   Inoue, Seiji ^a   Iguchi, Nobuo ^a   Hosoda, Saichi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Department of Radiology ^*  (Japan)

Author keywords

Acute coronary syndromes; Dynamic SPECT; Fatty acid metabolism; Iodine 123 beta methyl p iodophenyl pentadecanoic acid; Myocardial perfusion

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; FATTY ACID; FIBRINOLYTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; IMAGE QUALITY; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; FATTY ACIDS; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031813903     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Knapp FF, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986;12:S39-S44.
2. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated β-methyl-branched fatty acid analog, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
3. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
4. 123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism: a multi-center trial. Jpn J Nucl Med 1992;29:413-433.
5. 123I-labeled β-methyl-iodophenyl pentadecanoic acid in ischemic heart disease. Jpn J Nucl Med 1992;29:347-358.
6. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994; 21:283-291.
7. Franken PR, De Greeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-1765.
8. Franken PR, Dendale P, De Greeter F, et al. Incremental value of combined BMIPP and sestamibi scintigraphy to predict functional outcome early after acute myocardial infarction. J Nucl Med 1996;37:718-722.
9. Tamaki N, Tadamura E, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995;36:1974-1980.
10. 123-BMIPP myocardial imaging in patients with stable effort angina and unstable angina. Jpn J Nucl Med 1995;32:625-630.
11. Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994;35:1279-1285.
12. Ambrose KR, Kropp J, Lambert CR, et al. Back diffusion and release of metabolite ("X") contribute to washout of radioiodinated BMIPP from isolated rat hearts. Eur J Nucl Med 1991;18:671.
13. 123I-β-methyl-iodophenylpentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med 1989;15:341-345.
14. 123I-BMIPP). Jpn J Nucl Med 1991;28:781-690.
15. Nakajima K, Syuke N, Taki J, et al. A simulation of dynamic SPECT using radiopharmaceuticals with rapid clearance. J Nucl Med 1992;33:1200-1206.